Trinity Biotech

NASDAQ: TRIB · Real-Time Price · USD
1.63
-0.28 (-14.66%)
At close: Aug 15, 2025, 3:59 PM
1.51
-7.36%
After-hours: Aug 15, 2025, 07:52 PM EDT

Trinity Biotech Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-31.79M -24.02M -41.01M 875K
Depreciation & Amortization
1.86M 1.78M 2.33M 2.74M
Stock-Based Compensation
1.32M 2.07M 1.75M 1.1M
Other Working Capital
10.3M n/a 7.39M 5.59M
Other Non-Cash Items
17.74M 11.37M 37.85M 8.86M
Deferred Income Tax
486K -59K -192K -167K
Change in Working Capital
6.19M -2.69M -1.66M -172K
Operating Cash Flow
-4.19M -11.56M -921K 13.24M
Capital Expenditures
-10.06M -803K -5.98M -8.69M
Cash Acquisitions
-12.9M 28.16M n/a n/a
Purchase of Investments
n/a -700K n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-9.66M -1.9M -4.88M -6.88M
Investing Cash Flow
-22.97M 24.76M -5.98M -8.69M
Debt Repayment
27.67M -7.37M -27.04M -2.94M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-6.25M -8.67M 14.72M -3.08M
Financial Cash Flow
28.81M -16.04M -12.32M -6.02M
Net Cash Flow
1.48M -2.89M -19.33M -1.42M
Free Cash Flow
-14.26M -14.26M -6.9M 4.55M